The stock of Revolution Medicines Inc (NASDAQ: RVMD) has increased by 0.96 when compared to last closing price of 42.97. Despite this, the company has experienced a -3.45% fall in its stock price over the last five trading sessions. 247wallst.com reported 2024-12-15 that The year is winding down, and the stock markets are near all-time highs. Opinions on what the new year will bring vary wildly.
Is It Worth Investing in Revolution Medicines Inc (NASDAQ: RVMD) Right Now?
RVMD has 36-month beta value of 1.46. Analysts have mixed views on the stock, with 10 analysts rating it as a “buy,” 5 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for RVMD is 151.65M, and currently, short sellers hold a 10.65% ratio of that float. The average trading volume of RVMD on December 19, 2024 was 1.59M shares.
RVMD’s Market Performance
The stock of Revolution Medicines Inc (RVMD) has seen a -3.45% decrease in the past week, with a -23.18% drop in the past month, and a -4.49% fall in the past quarter. The volatility ratio for the week is 4.14%, and the volatility levels for the past 30 days are at 4.31% for RVMD. The simple moving average for the past 20 days is -12.95% for RVMD’s stock, with a 1.23% simple moving average for the past 200 days.
Analysts’ Opinion of RVMD
Many brokerage firms have already submitted their reports for RVMD stocks, with Needham repeating the rating for RVMD by listing it as a “Buy.” The predicted price for RVMD in the upcoming period, according to Needham is $62 based on the research report published on July 16, 2024 of the current year 2024.
Barclays, on the other hand, stated in their research note that they expect to see RVMD reach a price target of $52. The rating they have provided for RVMD stocks is “Overweight” according to the report published on July 12th, 2024.
Jefferies gave a rating of “Buy” to RVMD, setting the target price at $63 in the report published on July 08th of the current year.
RVMD Trading at -16.25% from the 50-Day Moving Average
After a stumble in the market that brought RVMD to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -30.48% of loss for the given period.
Volatility was left at 4.31%, however, over the last 30 days, the volatility rate increased by 4.14%, as shares sank -23.83% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -12.16% lower at present.
During the last 5 trading sessions, RVMD fell by -3.25%, which changed the moving average for the period of 200-days by +40.77% in comparison to the 20-day moving average, which settled at $49.84. In addition, Revolution Medicines Inc saw 51.26% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at RVMD starting from Horn Margaret A, who sale 4,329 shares at the price of $45.40 back on Dec 16 ’24. After this action, Horn Margaret A now owns 127,991 shares of Revolution Medicines Inc, valued at $196,553 using the latest closing price.
GOLDSMITH MARK A sale 11,714 shares at $45.40 during a trade that took place back on Dec 16 ’24, which means that GOLDSMITH MARK A is holding 325,056 shares at $531,860 based on the most recent closing price.
Stock Fundamentals for RVMD
Current profitability levels for the company are sitting at:
- -880.32 for the present operating margin
- -179.13 for the gross margin
The net margin for Revolution Medicines Inc stands at -764.23. The total capital return value is set at -0.4. Equity return is now at value -47.18, with -41.28 for asset returns.
Based on Revolution Medicines Inc (RVMD), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at -64.28. The debt to equity ratio resting at 0.01. The interest coverage ratio of the stock is -70.32.
Currently, EBITDA for the company is -430.58 million with net debt to EBITDA at 0.18. When we switch over and look at the enterprise to sales, we see a ratio of 10464.67. The liquidity ratio also appears to be rather interesting for investors as it stands at 14.24.
Conclusion
To put it simply, Revolution Medicines Inc (RVMD) has had a mixed performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
